Ackermann Michael 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Ackermann Michael
Director10% Owner
Transactions
- Sale
Common Stock
2021-09-01$25.24/sh−5,833$147,237→ 1,221,515 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $25.000 to $25.970, inclusive. The Reporting Person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.